Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Laine, Antti-Pekka | Holmberg, Hanna | Nilsson, Anita | Örtqvist, Eva | Kiviniemi, Minna | Vaarala, Outi; | Åkerblom, Hans K. | Simell, Olli | Knip, Mikael; | Ludvigsson, Johnny | Ivarsson, Sten-A | Larsson, Karin | Lernmark, Åke | Ilonen, Jorma;
Affiliations: Immunogenetics Laboratory, University of Turku, Turku, Finland | Department of Paediatrics, University of Turku, Turku, Finland | Department of Molecular and Clinical Medicine, Linköping University, Linköping, Sweden | Department of Endocrinology and Paediatrics, University Hospital Malmö, University of Lund, Lund, Sweden | Astrid Lindgren's Children Hospital, Karolinska Hospital, Stockholm, Sweden | Department of Viral Diseases and Immunology, National Public Health Institute, Helsinki, Finland | Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland | Department of Pediatrics, Tampere University Hospital, Tampere, Finland | Department of Clinical Microbiology, University of Kuopio, Kuopio, Finland
Note: [] Corresponding author: Antti-Pekka Laine, University of Turku/Medicity, Tykistokatu 6a, FIN-20520, Finland. Tel.: +358 2 3337023; Fax: +358 2 3337000; E-mail: aplaine@utu.fi
Abstract: We have developed high-throughput tests for the detection of the insulin gene region SNPs −23HphI and −2221MspI. The potential of these markers to enhance the efficiency of type 1 diabetes risk screening was then evaluated by analyzing them in Finnish and Swedish populations. Blood spots on filter paper were analyzed using PCR followed by sequence-specific hybridization and time-resolved fluorometry reading. Distribution of the genotypes at both positions differed significantly among the affected children compared to the controls. The risk genotypes (CC, AA) were significantly more common in Finland than in Sweden, both among patients and controls. The VNTR genotype homozygous for the protective class III alleles showed a significantly stronger protective effect than the heterozygote (p=0.02). Analyzing both SNPs enabled the detection of VNTR class III subclasses IIIA and IIIB. The observed significance between effects of the protective genotypes was due to the strong protective effect of the IIIA/IIIA genotype. IIIA/IIIA was the only genotype with significant discrepancy between protective effects compared to the other class III genotypes. These observations suggest that heterogeneity between the protective IDDM2 lineages could exist, and analyzing both −23HphI and −2221MspI would thus potentially enhance the sensitivity and specificity of type 1 diabetes risk estimation.
Keywords: Type 1 diabetes, insulin gene region, Finnish population, screening for genetic risk
Journal: Disease Markers, vol. 23, no. 3, pp. 139-145, 2007
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl